Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02289053 · ClinicalTrials.gov registry record
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 1,623
- Enrollment target
NCT02289053: Completed study, sponsored by University of Michigan.
NCT02289053 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 1,623 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02289053 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 1,623 participants
- Enrollment target
Study Summary
Conflicting guideline recommendations for screening colonoscopy result due to scant data upon which to develop appropriate recommendations. No previous study has compared the prevalence of advanced adenomas or adenomas (any size) among 40-49 year old individuals with a first degree relative (FDR) with colorectal cancer (CRC) versus 40-49 year old average risk individuals with no family history of CRC. The purpose of this study is to determine the prevalence of colon adenomas in 40-49 year old individuals and identify risk factors associated with the presence of advanced adenomas. This data will provide evidence to determine appropriate colon cancer screening guidelines in 40-49 year old persons with a family history of colon polyps or colorectal cancer.
Primary Outcome
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014. Advanced adenomas are defined as greater than or equal to 10 mm (1 cm). The presence of adenomas is determined be reviewing patient medical records and pathology reports.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,623 participants |
| Start Date | 2006-04-01 |
| Est. Completion | 2014-06-30 |
What the finished NCT02289053 record still lists
NCT02289053 is an observational study that tracks outcomes without assigning an intervention. Its 1,623 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02289053 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02289053 about?
NCT02289053 is a clinical study titled "Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer". Conflicting guideline recommendations for screening colonoscopy result due to scant data upon which to develop appropriate recommendations. No previous study has compared the prevalence of advanced adenomas or adenomas (any size) among 40-49 year old individuals with a first degree relative (FDR) wi...
What is the current status of trial NCT02289053?
This trial is currently completed. The enrollment target is 1,623 participants. The study started on 2006-04-01. Estimated completion is 2014-06-30.
Who is sponsoring clinical trial NCT02289053?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI